A Review of Osteoporosis: Part I. Impact, Pathophysiology, Diagnosis and Unique Role of the Physiatrist

PM and R

Volumn 1, Issue 3, 2009, Pages 254-260

  Kasturi, Gopi C ^a   Cifu, David X ^a   Adler, Robert A ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIANDROGEN; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; AROMATASE INHIBITOR; BISPHOSPHONIC ACID DERIVATIVE; CALCITRIOL; CALCIUM; CYTOTOXIC AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; ESTROGEN; GESTAGEN; GLUCOCORTICOID; GONADORELIN DERIVATIVE; NARCOTIC ANALGESIC AGENT; OPIATE; PARATHYROID HORMONE; PREDNISONE; PROTON PUMP INHIBITOR; TESTOSTERONE; THYROID HORMONE; VITAMIN D;

ACCIDENT PREVENTION; ARTICLE; BODY WEIGHT; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CALCIUM ABSORPTION; CHRONIC DISEASE; CLINICAL PRACTICE; CONSULTATION; DRUG INDUCED DISEASE; DUAL ENERGY X RAY ABSORPTIOMETRY; ENDOCRINE DISEASE; EXERCISE; FALLING; FRACTURE; GASTROINTESTINAL DISEASE; HEALTH CARE QUALITY; HIGH RISK PATIENT; HIP FRACTURE; HORMONE ACTION; HUMAN; HYPOGONADISM; LONG TERM CARE; MALNUTRITION; NUTRITION; OSTEOLYSIS; OSTEOPOROSIS; PAIN; PATHOPHYSIOLOGY; PHYSICAL MEDICINE; POSTMENOPAUSE OSTEOPOROSIS; PRACTICE GUIDELINE; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REHABILITATION MEDICINE; RISK REDUCTION; SEX DIFFERENCE; STEROID THERAPY; VITAMIN D DEFICIENCY;

ABSORPTIOMETRY, PHOTON; BONE REMODELING; FEMALE; HUMANS; MALE; OSTEOPOROSIS; PHYSICAL MEDICINE; QUALITY OF HEALTH CARE;

EID: 61649124549     PISSN: 19341482     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmrj.2008.12.005     Document Type: Article

References (61)

1. Mauck K.F., and Clarke B.L. Diagnosis, screening, prevention, and treatment of osteoporosis. Mayo Clin Proc 81 (2006) 662-672
2. US Department of Health and Human Services. Bone Health and Osteoporosis: A Report of the Surgeon General (2004), US Department of Health and Human Services, Rockville, MD
3. National Osteoporosis Foundation. NOF's new clinician's guide to prevention and treatment of osteoporosis. http://www.nof.org/professionals/Clinicians_Guide.htm Accessed July 21, 2008
4. Kuehn B.M. Better osteoporosis management a priority impact predicted to soar with aging population. JAMA 293 (2005) 2453-2458
5. Cummings S.R., and Melton L.J. Epidemiology and outcomes of osteoporotic fractures. Lancet 359 (2002) 1761-1767
6. Adler R.A. Epidemiology and pathophysiology of osteoporosis in men. Curr Osteoporos Rep 4 (2006) 110-115
7. Lenchik L., Rogers L.F., Delmas P.D., and Genant H.K. Diagnosis of osteoporotic vertebral fractures: importance of recognition and description by radiologists. Am J Roentgenol 183 (2004) 949-958
8. Kado D.M., Browner W.S., Palermo L., Nevitt M.C., Genant H.K., and Cummings S.R. Vertebral fractures and mortality in older women: a prospective study. Arch Intern Med 159 (1999) 1215-1220
9. Pluijm S.M., Tromp A.M., Smit J.H., Deeg D.J., and Lips P. Consequences of vertebral deformities in older men and women. J Bone Miner Res 15 (2000) 1564-1572
10. Adler R.A. Epidemiology and pathophysiology of osteoporosis in men. Curr Osteoporos Rep 4 (2006) 110-115
11. Hansen M.A., Overgaard K., Riis B.J., and Christiansen C. Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study. BMJ 303 (1991) 961-964
12. O'Flaherty E.J. Modeling normal aging bone loss, with consideration of bone loss in osteoporosis. Toxicol Sci 55 (2000) 171-188
13. Raisz L.G. Physiology and pathophysiology of bone remodeling. Clin Chem 45 8 Pt 2 (1999) 1353-1358
14. Parfitt A. What is the normal rate of bone remodeling?. Bone 35 (2004) 1-3
15. Overview of osteoporosis. In: Bruder J., Tanner S.B., Leib E., Kendler D., and Binkley N. (Eds). ISCD Bone Densitometry Clinician Course Syllabus and Associated Reading Materials (2007), The International Society for Clinical Densitometry, West Hartford, CT 10-23
16. Kanis J.A. FRAX WHO Fracture Risk Assessment Tool. World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UK. http://www.shef.ac.uk/FRAX/index.htm Accessed July 22, 2008
17. Cummings S.R., Bates D., and Black D.M. Clinical use of bone densitometry: scientific review. JAMA 288 (2002) 1889-1897
18. Tannenbaum C., Clark J., Schwartzman K., et al. Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. J Clin Endocrinol Metab 87 (2002) 4431-4437
19. Vieth R., Bischoff-Ferrari H., Boucher B.J., et al. The urgent need to recommend an intake of vitamin D that is Effective. Am J Clin Nutr 85 (2007) 649-650
20. Holick M.F., and Chen T.C. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 87 (2008) 1080S-1086S
21. Ivaska K.K., Lenora J., Gerdhem P., Akesson K., Väänänen H.K., and Obrant K.J. Serial assessment of serum bone metabolism markers identifies women with the highest rate of bone loss and osteoporosis risk. J Clin Endocrinol Metab 93 (2008) 2622-2632
22. Hamdy R.C. Our osteoporosis report card: 'A' for apathy, 'D' for effort, and 'F' for results. South Med J 97 (2004) 538-539
23. Johnson S.L., Petkov V.I., Williams M.I., Via P.S., and Adler R.A. Improving osteoporosis management in patients with fractures. Osteoporos Int 16 (2005) 1079-1085
24. Hajcsar E.E., Hawker G., and Bogoch E.R. Investigation and treatment of osteoporosis in patients with fragility fractures. CMAJ 163 (2000) 819-822
25. Harrington J.T., Broy S.B., Derosa A.M., Licata A.A., and Shewmon D.A. Hip fracture patients are not treated for osteoporosis: a call to action. Arthritis Rheum 47 (2002) 651-654
26. Juby A.G., and De Geus-Wenceslau C.M. Evaluation of osteoporosis treatment in seniors after hip fracture. Osteoporos Int 13 (2002) 205-210
27. Khan S.A., de Geus C., Holyroyd B., and Russell A.S. Osteoporosis follow-up after wrist fractures following minor trauma. Arch Intern Med 161 (2001) 1309-1312
28. Dreinhöfer K.E., Anderson M., Féron J.M., et al. Multinational survey of osteoporotic fracture management. Osteoporos Int 16 (2005) S44-S53
29. Siris E.S., Bilezikian J.P., Rubin M.R., et al. Pins and plaster aren't enough: a call for the evaluation and treatment of patients with osteoporotic fractures. J Clin Endocrinol Metab 88 (2003) 3482-3486
30. Gardner M.J., Flik K.R., Mooar P., and Lane J.M. Improvement in the undertreatment of osteoporosis following hip fracture. J Bone Joint Surg Am 84-A (2002) 1342-1348
31. Melton III L.J., Thamer M., Ray N.F., et al. Fractures attributable to osteoporosis: report for the National Osteoporosis Foundation. J Bone Miner Res 12 (1997) 16-23
32. Simonelli C., Chen Y.T., Morancey J., Lewis A.F., and Abbott T.A. Evaluation and management of osteoporosis following hospitalization for low impact fracture. J Gen Intern Med 18 (2003) 17-22
33. Elliot-Gibson V., Bogoch E.R., Jamal S.A., and Beaton D.E. Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int 15 (2004) 767-778
34. Chami G., Jeys L., Freudmann M., Connor L., and Siddiqi M. Are osteoporotic fractures being adequately investigated?. A questionnaire of GP & orthopaedic surgeons. BMC Fam Pract 7 (2006) 7
35. Mackey D.C., Lui L.Y., Cawthon P.M., et al. High-trauma fractures and low bone mineral density in older women and men. JAMA 298 (2007) 2381-2388
36. Sanders K.M., Pasco J.A., Ugoni A.M., et al. The exclusion of high trauma fractures may underestimate the prevalence of bone fragility fractures in the community: the Geelong Osteoporosis Study. J Bone Miner Res 13 (1998) 1337-1342
37. Kaufman J.D., Bolander M.E., Bunta A.D., Edwards B.J., Fitzpatrick L.A., and Simonelli C. Barriers and solutions to osteoporosis care in patients with a hip fracture. J Bone Joint Surg Am 85-A (2003) 1837-1843
38. Warriner A., Curtis J.R., and Saag K.G. Challenges in defining and improving osteoporosis quality of care. Clin Exp Rheumatol 25 Suppl 47 (2007) 142-146
39. Simonelli C., Killeen K., Mehle S., and Swanson L. Barriers to osteoporosis identification and treatment among primary care physicians and orthopedic surgeons. Mayo Clin Proc 77 (2002) 334-338
40. Black D.M., Thompson D.E., Bauer D.C., et al. Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab 85 (2000) 4118-4124
41. Harris S.T., Watts N.B., Genant H.K., et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. JAMA 282 (1999) 1344-1352
42. Reginster J., Minne H.W., Sorensen O.H., et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int 11 (2000) 83-91
43. Bahl S., Coates P.S., and Greenspan S.L. The management of osteoporosis following hip fracture: have we improved our care?. Osteoporos Int 14 (2003) 884-888
44. Streeten E.A., Mohamed A., Gandhi A., et al. The inpatient consultation approach to osteoporosis treatment in patients with a fracture. Is automatic consultation needed?. J Bone Joint Surg Am 88 (2006) 1968-1974
45. Pazirandeh M. Does patient partnership in continuing medical education (CME) improve the outcome in osteoporosis management?. J Contin Educ Health Prof 22 (2002) 142-151
46. Majumdar S.R., Johnson J.A., Lier D.A., et al. Persistence, reproducibility, and cost-effectiveness of an intervention to improve the quality of osteoporosis care after a fracture of the wrist: results of a controlled trial. Osteoporos Int 18 (2007) 261-270
47. van Helden S., Cauberg E., Geusens P., Winkes B., van der Weijden T., and Brink P. The fracture and osteoporosis outpatient clinic: an effective strategy for improving implementation of an osteoporosis guideline. J Eval Clin Pract 13 (2007) 801-805
48. Gardner M.J., Brophy R.H., Demetrakopoulos D., et al. Interventions to improve osteoporosis treatment following hip fracture. A prospective, randomized trial. J Bone Joint Surg Am 87 (2005) 3-7
49. Davis J.C., Guy P., Ashe M.C., Liu-Ambrose T., and Khan K. Hip watch: osteoporosis investigation and treatment after a hip fracture: a 6-month randomized controlled trial. J Gerontol A Biol Sci Med Sci 62 (2007) 888-891
50. Gold D.T., and Silverman S.L. Osteoporosis self-management: choices for better bone health. South Med J 97 (2004) 551-554
51. Bogoch E.R., Elliot-Gibson V., Beaton D.E., Jamal S.A., Josse R.G., and Murray T.M. Effective initiation of osteoporosis diagnosis and treatment for patients with a fragility fracture in an orthopaedic environment. J Bone Joint Surg Am 88 (2006) 25-34
52. Zerwekh J.E., Ruml L.A., Gottschalk F., and Pak C.Y. The effects of twelve weeks of bed rest on bone histology, biochemical markers of bone turnover, and calcium homeostasis in eleven normal subjects. J Bone Miner Res 13 (1998) 1594-1601
53. Zehnder Y., Lüthi M., Michel D., et al. Long-term changes in bone metabolism, bone mineral density, quantitative ultrasound parameters, and fracture incidence after spinal cord injury: a cross-sectional observational study in 100 paraplegic men. Osteoporos Int 15 (2004) 180-189
54. Ramnemark A., Nyberg L., Lorentzon R., Englund U., and Gustafson Y. Progressive hemiosteoporosis on the paretic side and increased bone mineral density in the nonparetic arm the first year after severe stroke. Osteoporos Int 9 (1999) 269-275
55. Nieves J., Cosman F., Herbert J., Shen V., and Lindsay R. High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology 44 (1994) 1687-1692
56. Vaserman N. Parkinson's disease and osteoporosis. Joint Bone Spine 72 (2005) 484-488
57. Alenfeld F.E., Diessel E., Brezger M., Sieper J., Felsenberg D., and Braun J. Detailed analyses of periarticular osteoporosis in rheumatoid arthritis. Osteoporos Int 11 (2000) 400-407
58. Peel N.F., Moore D.J., Barrington N.A., Bax D.E., and Eastell R. Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis 54 (1995) 801-806
59. Lee J.I., Kim J.H., Kim H.W., et al. Changes in bone metabolism in a rat model of traumatic brain injury. Brain Inj 19 (2005) 1207-1211
60. Daniell H.W. Hypogonadism in men consuming sustained-action oral opioids. J Pain 3 (2002) 377-384
61. Boling E.P. Secondary osteoporosis: underlying disease and the risk for glucocorticoid-induced osteoporosis. Clin Ther 26 (2004) 1-14